SNDX – Syndax Pharmaceuticals, Inc.

SNDX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

23.37

Margin Of Safety %

Put/Call OI Ratio

0.31

EPS Next Q Diff

0.08

EPS Last/This Y

1.54

EPS This/Next Y

1.57

Price

20.42

Target Price

39.33

Analyst Recom

1.08

Performance Q

-4.27

Upside

-580.2%

Beta

0.42

Ticker: SNDX

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	SNDX	24.24	0.30	0.35	15645
2026-04-14	SNDX	24.44	0.30	0.99	16038
2026-04-15	SNDX	24.31	0.32	1.19	16619
2026-04-17	SNDX	24.22	0.32	0.08	16109
2026-04-20	SNDX	23.76	0.16	0.08	7594
2026-04-21	SNDX	23.3	0.16	0.42	7698
2026-04-23	SNDX	20.99	0.19	0.48	8875
2026-04-24	SNDX	21.38	0.28	1.00	13630
2026-04-27	SNDX	21	0.28	0.51	13693
2026-04-28	SNDX	21.12	0.28	3.88	13756
2026-04-29	SNDX	20.62	0.30	0.23	13985
2026-04-30	SNDX	21.45	0.30	0.12	14043
2026-05-01	SNDX	19.12	0.29	5.16	15000
2026-05-04	SNDX	19.96	0.39	0.44	16295
2026-05-05	SNDX	20.08	0.38	0.52	16381
2026-05-06	SNDX	20.64	0.40	0.46	19483
2026-05-07	SNDX	20.53	0.41	0.08	22589
2026-05-08	SNDX	21.5	0.41	0.01	22591
2026-05-11	SNDX	21.37	0.33	0.03	26419
2026-05-12	SNDX	20.42	0.31	0.02	27810
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	SNDX	24.23	38.3	148.8	-1.80
2026-04-14	SNDX	24.42	38.3	148.0	-1.80
2026-04-15	SNDX	24.33	38.3	148.4	-1.80
2026-04-16	SNDX	23.78	38.3	150.8	-1.80
2026-04-17	SNDX	24.20	38.3	148.9	-1.80
2026-04-20	SNDX	23.76	38.3	150.8	-1.74
2026-04-21	SNDX	23.32	38.3	152.8	-1.74
2026-04-22	SNDX	22.08	38.3	158.3	-1.74
2026-04-23	SNDX	20.99	39.3	163.0	-1.74
2026-04-24	SNDX	21.39	39.3	161.3	-1.74
2026-04-27	SNDX	21.00	39.3	163.0	-1.74
2026-04-28	SNDX	21.12	39.7	162.4	-1.75
2026-04-30	SNDX	21.41	39.7	161.2	-1.75
2026-05-01	SNDX	19.10	39.7	171.3	-1.75
2026-05-04	SNDX	19.96	39.7	-	-1.65
2026-05-05	SNDX	20.10	44.0	-	-1.77
2026-05-06	SNDX	20.65	44.0	-	-1.77
2026-05-07	SNDX	20.54	44.2	-	-1.77
2026-05-08	SNDX	21.50	44.2	-	-1.77
2026-05-11	SNDX	21.37	43.4	-	-1.75
2026-05-12	SNDX	20.42	43.4	-	-1.75
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	SNDX	-0.86	-1.12	24.42
2026-04-14	SNDX	-0.86	-1.12	24.42
2026-04-15	SNDX	-0.86	-1.12	24.42
2026-04-16	SNDX	-0.86	-1.12	24.42
2026-04-17	SNDX	-0.86	-1.12	24.42
2026-04-20	SNDX	-0.86	-1.12	24.42
2026-04-21	SNDX	-0.86	-1.12	24.42
2026-04-22	SNDX	-0.86	-1.12	24.41
2026-04-23	SNDX	-0.88	-1.12	24.41
2026-04-24	SNDX	-0.88	-1.12	24.41
2026-04-27	SNDX	-0.88	0.54	24.73
2026-04-28	SNDX	-0.88	0.54	24.73
2026-04-29	SNDX	-0.88	0.54	24.73
2026-04-30	SNDX	-0.88	0.54	24.73
2026-05-01	SNDX	-0.88	0.54	24.73
2026-05-04	SNDX	-0.88	-0.71	24.73
2026-05-05	SNDX	-0.88	-0.71	24.73
2026-05-06	SNDX	-0.87	-0.71	24.73
2026-05-07	SNDX	-0.87	-0.71	24.61
2026-05-08	SNDX	-0.87	-0.71	24.61
2026-05-11	SNDX	-0.87	-0.76	24.61
2026-05-12	SNDX	-0.87	-0.76	23.37
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.48

Avg. EPS Est. Current Quarter

-0.47

Avg. EPS Est. Next Quarter

-0.4

Insider Transactions

-0.87

Institutional Transactions

-0.76

Beta

0.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

31.6

Max Drawdown 5-Year %

-69.9

Target Price

39.33

P/E

Forward P/E

PEG

P/S

8.32

P/B

43.42

P/Free Cash Flow

EPS

-2.8

Average EPS Est. Cur. Y

-1.75

EPS Next Y. (Est.)

-0.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-111.88

Relative Volume

0.77

Return on Equity vs Sector %

-611.3

Return on Equity vs Industry %

-595.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ SNDX Healthcare

$20.41

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

14/20

Pullback

11/25

Volume

6/15

Valuation

9/20

TP/AR

3/10

Options

8/10

RSI

41.3

Range 1M

24.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

25/30

Estimates

2/20

Inst/Vol

1/15

Options

8/10

EPS Yr

45.3%

EPS NY

69.3%

52W%

70.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +92.7% upside

Quality

6/30

Valuation

14/30

Growth

20/25

Stability

5/10

LT Trend

1/5

Upside

+92.7%

Quality

Syndax Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 298

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.

SNDX

Latest News

—

Caricamento notizie per SNDX…

stock quote shares SNDX – Syndax Pharmaceuticals, Inc. Stock Price stock today

news today SNDX – Syndax Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch SNDX – Syndax Pharmaceuticals, Inc. yahoo finance google finance

stock history SNDX – Syndax Pharmaceuticals, Inc. invest stock market

stock prices SNDX premarket after hours

ticker SNDX fair value insiders trading

SNDX – Syndax Pharmaceuticals, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y